Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 3Active not recruiting 2Terminated 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Neurofibromatosis 1 2Neoplasms 2Smoking Cessation 1Smoking 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma, Follicular 1Head and Neck Neoplasms 1Fatigue 1Cognition Disorders 1Carcinoma, Hepatocellular 1Cancer Pain 1Breast Neoplasms 1Bone Neoplasms 1Anxiety Disorders 1Anti-N-Methyl-D-Aspartate Receptor Encephalitis 1Agnosia 1Abdominal Pain 1

Interventions

Trastuzumab 350Paclitaxel 334Cyclophosphamide 315Docetaxel 291Capecitabine 181Doxorubicin 180Letrozole 166Tamoxifen 145Bevacizumab 124Fulvestrant 118Carboplatin 118exemestane 111Lapatinib 111Anastrozole 111Radiotherapy 105Epirubicin 104Gemcitabine 97palbociclib 84Exercise 78Vinorelbine 77Fluorouracil 77Surveys and Questionnaires 71pertuzumab 67Filgrastim 64Albumin-Bound Paclitaxel 64eribulin 55Magnetic Resonance Spectroscopy 55Everolimus 52Blood Specimen Collection 51Zoledronic Acid 50

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Breast Neoplasms × Transcranial Direct Current Stimulation × Clear all
NCT03487601 2021-01-15

Transcranial Direct Current Stimulation (tDCS) to Improve Fatigue and Cognitive Function

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase NA Completed
3 enrolled
Breast

Breast Neoplasms, Fatigue

Data powered by HemOnc (CC BY 4.0) Colophon âš¡